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ABSTRACT
A simple HPLC with UV detection method is developed and validated for determination of
Bovine Serum Albumin and Myoglobin proteins in a standard solution of the two protein
as well as in a plasma spiked with theses two proteins. Separation was achieved on a
reversed-phase C18, 5.0 µm, 150mm × 4.6 mm inner diameter column using a mobile
phase consisting of solution A (900 mL of water, 100 mL Acetonitrile, 10 mL Trifluroacetic
acid) and solution B (900 mL of acetonitrile, 100 mL water, 10 mL Trifluroacetic acid) with
gradient elution of 5 to 50% of solution B in 15 minutes. This new method is validated in
accordance with requirements for new methods, which include accuracy, precision,
selectivity, linearity and range, robustness, limit of detection and limit of quantitation. The
method demonstrates good linearity over the range of 1-1000 ppm for the two proteins
with r2 greater than 0.998. The percentage recovery of the method is within 97.9 to
102.0% for the two proteins. Precision of this method reflected by relative standard
deviation of the area of six replicate injections of each protein at five concentration levels
(1.0, 100.0, 300.0, 500, and 1000.0 ppm) was found to be less than 2%. Limit of
quantitation of the two proteins is low which enables the determination of these proteins at
low concentration.
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1. INTRODUCTION
Bovine serum albumin (BSA) is a serum albumin protein derived from cows with 607 amino
acids. BSA has numerous biochemical applications including ELISAs (Enzyme-Linked
Immunosorbent Assay), immunoblots, and immunohistochemistry. It is also used as a
nutrient in cell and microbial culture [1]. Myoglobin is an iron- and oxygen-binding protein
found in the muscle tissue of vertebrates in general and in almost all mammals. It is related
to hemoglobin, which is the iron- and oxygen-binding protein in blood, specifically in the red
blood cells. Myoglobin is only found in the bloodstream after muscle injury. It is an abnormal
finding, and can be diagnostically relevant when found in blood [2]. Myoglobin is a single-
chain globular protein of 153 or 154 amino acids, containing a heme (iron-containing
porphyrin) prosthetic group in the center around which the remaining apoprotein folds. It has
eight alpha helices and a hydrophobic core. It has a molecular weight of 17,699 daltons (with
heme). Unlike the blood-borne hemoglobin, to which it is structurally related, this protein
does not exhibit cooperative binding of oxygen, since positive cooperativity is a property of
multimeric/oligomeric proteins only [3].
Many methods has been developed for analysis of bovine serum albumin [4-5] and
myoglobin [6-7] by HPLC, however a simple reversed phase HPLC method for simultaneous
determination of the two proteins was not reported so far. In this respect, a method for
simultaneous determination of these two proteins is needed and presented in this work. The
analytical method employed for the analysis of these proteins in the current work is simple
where HPLC technique is employed. Furthermore, UV detector was employed for the
detection of these proteins where it is available in most of analytical labs in contrary to other
detectors like fluorescence and mass spectrometry which are not available in many analysis
labs. Additionally this method was validated in accordance of new methods which include
linearity and range, precision, accuracy, selectivity, limit of detection, limit of quantitation,
and ruggedness.
2. EXPERIMENTALS
2.1 Chemicals
Acetonitrile (HPLC grade), Trifluroacetic acid, and standards of the two proteins are from
Merck (Darmstadt, Germany).
2.2 Apparatus
HPLC system (Merck Hitachi Lachrom Elite HPLC system, Japan) with a pump, an
autosampler, column oven, and a UV-detector was employed. The chromatographic column
C18 (15cm length, 4.6 mm inner diameter, and 4.6 µm particles) is from Waters Corporation
(Milford, Massachusetts, USA).
2.3 Standard Solutions Preparation
2.3.1 Standard solutions for linearity and range
Stock standard solution of the two proteins (1000 ppm) was prepared in phosphate buffer pH
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7.2. Different concentrations of each protein were then prepared from the stock solution by
dilution using phosphate buffer pH 7.2 as diluent. The following diluted concentrations were
prepared: 1.0, 20.0, 100.0, 300, 500.0, 700.0, and 1000.0 ppm. Each of these solutions was
injected into the HPLC and peak areas were recorded and plotted versus the concentration
of the protein.
2.3.2 Percentage recovery (Accuracy) of the method
Five recovery solutions were prepared by spiking the proteins in phosphate buffer pH 7.2 at
five concentration levels (1.0, 100.0, 300, 500.0, and 1000.0 ppm).
2.3.3 Limit of detection (LOD) and limit of quantitation (LOQ)
LOD of the proteins was determined by preparing a set of solutions with low concentrations
of the two proteins (0.1, 0.3, 0.7, and 1.0 ppm) that is expected to produce a response that is
3-20 times baseline noise. The solutions are injected and the signal to noise ratio (S/N) are
recorded. LOD is selected as the concentration of protein that gives a S/N ratio of 3-10. LOQ
is determined in the same manner and selected as the concentration of protein that gives an
S/N ratio of 10-20.
3. RESULTS AND DISCUSSION
3.1 Method Development
Preliminary studies involved trying C8 and C18 reversed-phase columns and testing several
mobile phase compositions and using different chromatographic parameters for the
separation of the two proteins. The chromatographic separation was started with C8 column
(12.5 and 25.0 cm length) but it did not show good separation (poor resolution, less than
1.5). Therefore C18 column was the next choice for separation of the two proteins. C18
column with 15 and 25cm length was tested for separation of the two proteins, and it was
found that C18 column with 25 cm length gave higher retention times with a low theoretical
plates, while C18 column (15 cm) gave a good separation with a reasonable retention time,
and good theoretical plates. Therefore C18 column with 15 cm length (4.6 mm inner
diameter, and 5.0 µm particles) was used for separation of the two proteins. Regarding the
mobile phase, different mixtures of acetonitrile and water as well as mixtures of methanol
and water was tested in both isocratic and gradient modes, but the separation was poor (low
resolution) and the shape of the peaks is not good (low theoretical plates). However when
trifluroacetic acid was added to a mixture of water and acetonitrile, the shape of the peaks of
the proteins become good. The volume fraction of trifluroacetic acid in the mobile phase was
optimized and found to be 1%. Isocratic elution gave poor separation of the two proteins;
therefore gradient elution was used for separation of these two proteins. Gradient elution
was optimized for solution A (900 mL of water, 100 mL Acetonitrile, 10 mL Trifluroacetic acid)
and solution B (900 mL of acetonitrile, 100 mL water, 10 mL Trifluroacetic acid), and found
that 5 to 50% of solution B in 15 minutes at a flow rate of 0.8 ml/min is the optimum condition
for separation of the two proteins. The apparent pH of solution A an B is 2. Concerning the
wavelength of the detector, it was chosen to be 220 nm as it gave higher peak heights and
areas and consequently higher sensitivity for both proteins. Wavelength lower than 220 nm
gave higher peak areas (higher sensitivity) but the selectivity decreases since mobile phase
absorb at this wavelength. On the other hand, higher wavelength gave low sensitivity,
therefore 220 nm was the best wavelength for determination of these proteins. Injection
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volume was chosen to be 20 µL as it gave good peak areas even at low concentration of the
two proteins. Higher and lower injection volumes can also be used, but low injection volumes
give low sensitivity, while higher injection volumes give broad peaks and nonlinear peak
areas. Therefore an injection volume of 20 µL was used for all standards and samples in this
study. Fig. 1 shows a chromatogram of bovine serum albumin and myoglobin standards,
while Fig. 2 shows a chromatogram of a serum sample spiked with bovine serum albumin
and myoglobin at 50 ppm concentration of each protein.
Fig. 1. Chromatogram of bovine serum albumin BSA (1) and Myoglobin (2). Column:
C18, 5 µm, 15 cm length, 4.6 mm inner diameter, UV detection: 220 nm. Mobile phase:
gradient of solution A (900 mL of water, 100 mL Acetonitrile, 10 mL Trifluroacetic acid)
and solution B (900 mL of acetonitrile, 100 mL water, 10 mL Trifluroacetic acid), 5 to
50% of B in 15 minutes, flow rate: 0.8 ml/min, injection volume: 20 µL
Fig. 2. Chromatogram of Bovine Serum Albumin BSA (1) and Myoglobin (2) spiked at a
concentration of 50ppm in a serum sample. For other chromatographic conditions,
see the legend of Fig. 1.
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3.2 Method Validation
3.2.1 Linearity and range
Linearity is the ability of a method to elicit test results that are directly proportional to analyte
concentration within a given range. Range is the interval between the upper and lower levels
of analyte that have been demonstrated to be determined with precision, accuracy, and
linearity using the method as written. A minimum of five concentration levels, along with
certain minimum specified ranges are required. Acceptance criteria for linearity are that the
correlation coefficient (r2) is not less than 0.990 for the least squares method of analysis of
the line [8].
To evaluate linearity of the current method for determination of the two proteins, different
calibration standards of the proteins were analyzed by HPLC-UV and the responses are
recorded. A plot of the peak areas of the proteins versus concentration (in ppm) was found to
be linear in the range of 1-1000 ppm for the two proteins with r2 greater than 0.998, see Fig.
3. This result indicates that these proteins can be determined at wide concentration range.
The concentration range of linearity (1-1000 ppm) was selected in order to test the ability of
the method for determination/quantitation of the proteins at wide concentration range.
Fig. 3. Plot of peak areas vs. concentration of myoglobin and Bovine serum Albumin
(linearity test)
3.2.2 Percentage recovery (accuracy)
The accuracy of an analytical method measures the closeness between the value, which is
accepted either as a conventional true value or an accepted reference value, and value
found (i.e., accuracy is a measure of exactness of an analytical method). Accuracy is
measured as the percent of analyte recovered after spiking samples in a blank. To document
accuracy, a minimum of nine determinations over a minimum of three concentration levels
covering the specified range (for example, three concentrations, three replicates for each)
were collected. It is performed at three concentrations covering the range of the method. At
each level studied, replicate samples are evaluated. The RSD of the replicates provides the
analysis variation and gives an indication of the precision of the test method. Moreover, the
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mean of the replicates, expressed as % of label claim, indicates the accuracy of the test
method. The mean recovery of the assay should be within 100±5.0% at each concentration
over the studied range [9].
For determination of the percentage recovery of the investigated proteins, these proteins are
spiked in phosphate buffer pH 7.2 followed by analysis by HPLC-UV. The average recovery
for each level has been calculated by proportion of the area of the peak of proteins resulted
from the spiked solution to the area of the peak of that protein resulted from a standard
solution prepared from standard of that protein. The average recovery and the RSD for each
level have been calculated. Results have showed that the current method has good recovery
(from 97.9 to 102.0%) for the two proteins at the five concentration levels studied (1.0, 100.0,
300.0, 500.0, and 1000.0 ppm), and with a relative standard deviation lower than 2.0%, see
Table 1.
Table 1. % recovery of bovine serum albumin and myoglobin at five concentration
levels (1, 100, 300.0, 500.0, and 1000 ppm)
Protein % Recovery
Concentration (ppm)
1.0 100.0 300.0 500.0 1000.0
Bovine
serum
albumin
102.0, 101.3,
100.7
Mean: 101.3
SD: 0.65
RSD: 0.64
98.4, 97.9,
101.0
Mean: 99.1
SD: 1.66
RSD: 1.68%
98.3, 98.6,
99.2
Mean: 98.7
SD: 0.46
RSD: 0.46%
101.6, 101.0,
102.0
Mean: 101.5
SD: 0.50
RSD: 0.50%
102.0, 101.1,
100.7
Mean: 101.3
SD: 0.67
RSD: 0.66
Myoglobin 97.9, 98.1,
99.1
Mean: 98.4
SD: 0.64
RSD: 0.65%
99.6, 100.7,
101.2
Mean: 100.5
SD: 0.82
RSD: 0.81%
98.2, 99.3,
99.1
Mean: 98.9
SD: 0.59
RSD: 0.59%
100.6, 101.3,
101.9
Mean: 101.3
SD: 0.65
RSD: 0.64%
99.8, 99.1,
100.3
Mean: 99.7
SD: 0.60
RSD: 0.60%
*SD: Standard Deviation.
**RSD: Relative Standard Deviation
3.2.3 Precision
Precision is the measure of the degree of repeatability of an analytical method under normal
operation and is normally expressed as the RSD for a statistically significant number of
samples. There are two types of precision: repeatability and intermediate precision
(ruggedness).
3.2.3.1 Repeatability
Repeatability is the closeness of agreement between mutually independent test results
obtained with the same method on identical test material in the same laboratory by the same
operator using the same equipment within short intervals of time. It is determined from a
minimum of nine determinations covering the specified range of the procedure (for example,
three levels, three repetitions each). RSD for replicate injections should not be greater than
1.5% [10].
Repeatability of the current method for determination of the two proteins was evaluated by
calculating the RSD of the peak areas of six replicate injections of standard solutions with
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five concentrations (1.0, 100.0, 300.0, 500.0, and 1000.0 ppm), which was found to be less
than 1.0% (Table 2). These results show that the current method for determination of the
proteins is repeatable.
Table 2. Repeatability of the method for determination of bovine serum albumin and
myoglobin proteins
Concentration
(ppm)
Bovine Serum Albumin protein Myoglobin protein
SD of the peak
areas of six
replicate
injections
RSD of the
peak areas of
six replicate
injections
SD of the peak
areas of six
replicate
injections
RSD of the
peak areas of
six replicate
injections
1 0.27 0.30% 0.43 0.47%
100 0.77 0.81% 0.72 0.70%
300 0.76 0.79% 0.85 0.88%
500 0.61 0.63% 0.60 0.61%
1000 0.90 0.88% 0.53 0.50%
*SD: Standard Deviation.
**RSD: Relative Standard Deviation
3.2.3.2 Intermediate precision (ruggedness)
Intermediate precision (also called ruggedness) of a method measures the repeatability of
the result obtained with the same method, on the same sample, in the same laboratory, but
by different operators and in different day. Intermediate precision of the current method was
evaluated by calculating the % recovery of the proteins at five concentration levels (1.0,
100.0, 300.0, 500.0, and 1000.0 ppm) by another analyst in different day. Results of this
study showed that the % recovery obtained by the second analyst is comparable to that
obtained by the main analyst and ranges from 98.1 to 101.8% (data not shown), indicating
that this method is rugged.
3.2.4 Selectivity
Selectivity of a method is the ability to assess unequivocally the analyte in the presence of
other analytes and other components that may be expected to be present in the matrix or
sample [11]. It is a measure of the degree of interferences from such components, ensuring
that a response is due to a single component only. Selectivity of the current method was
demonstrated by good separation of the two proteins from each other with good resolution
(resolution is 4.1, see Fig. 1). Additionally this method is specific for determination of these
two proteins in serum sample, where the two proteins are good separated (resolution is
higher than 3), and the bovine serum albumin (peak 1) is separated from the adjacent peak
(which is from the serum sample) with a resolution higher than 3, see Fig. 2.
3.2.5 Robustness
Robustness measures how a method stands up to slight variations in the operating
parameters of the method like flow rate, wavelength, percentage of mobile phase
composition. Robustness of the current method was investigated by measuring the %
recovery of the proteins at 100ppm concentration using the same developed method in this
study but changing deliberately one chromatographic condition each time. The
chromatographic conditions which were changed are (a) flow rate (0.6 and 1.0 mL/min vs.
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the original flow rate of 0.8 mL/min), and (b) wavelength (218 and 222 nm vs. the original
wavelength of 220 nm). Results have shown that separation is not affected by changing
slightly the chromatographic conditions; resolution between adjacent proteins remained
good. Additionally, the % recovery of the proteins was not affected significantly by changing
the chromatographic conditions (flow rate, and wavelength), see Table 3.
Table 3. Robustness testing for determination of bovine serum albumin and
myoglobin
Parameter % Recovery
Bovine serum albumin Myoglobin
Flow rate 0.6 100.7% 101.3%
0.8 99.1% 100.5%
1.0 99.8% 100.7%
Wavelength 218 100.7% 98.5%
220 99.1% 100.5%
222 99.8% 100.7%
3.2.6 Limit of detection (LOD) and limit of quantitation (LOQ)
LOD is the lowest concentration of analyte in a sample that can be detected but not
necessarily quantitated under the stated experimental conditions. It can be determined by
preparing a solution that is expected to produce a response that is about 3 to 10 times base
line noise. The solution is injected three times, and the signal to noise ratio for each injection
are recorded. The concentration of the solution is considered as a LOD if the S/N ratio is
between 3 and 10. LOQ can be determined in the same manner but with S/N ratio of 10-20.
LOD and LOQ of the proteins investigated in this study using the current method were found
to be low (see Table 4) which enables the detection and quantitation of these proteins at low
concentration levels.
Table 4. LOD and LOQ of bovine serum albumin and myoglobin using the method
employed in this study
Protein LOD (in ppm) LOQ (in ppm)
Bovine serum albumin 0.3 1.0
Myoglobin 0.4 1.0
4. CONCLUSION
A simple, accurate, precise, and selective HPLC method has been developed and validated
for the simultaneous determination of bovine serum albumin and myoglobin. The method is
linear for determination of these proteins with a wide dynamic range (1-1000 ppm). This
method is also accurate where the % recovery of the proteins is within 97.9 to 102.0%.
Precision of the method is confirmed by low RSD of replicate samples of the proteins. Low
LOD and LOQ of the proteins analyzed in this study enable the detection and quantitation of
them at low concentrations. The method of analysis is simple, the analysis time is short,
elution is isocratic, and the detector is UV detector which is available in most of separation
labs.
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